Nutritional Risk for Hospitalized Patients With Neurology Disorders in China

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXuanwu Hospital, Beijing

About this trial

Neurology disorders are one of the major public health problems that seriously threaten human health. It often accompanied by various nutritional problems, which can aggravate the primary disease, lead to serious complications, prolong the hospitalization, lead to poor prognosis, and increase family and social economic burdens. According to the previous studies, the risk of malnutrition was approximately 58.5% of stroke patients, and 6% had moderate to severe malnutrition in China. Another study conducted in Beijing showed that the risk of malnutrition of elderly patients in the department of neurology was significantly higher than in other departments (28.5% vs. 26.4%). Strengthening nutritional supervision of patients with neurology disorders will benefit to improve patients' prognosis. Therefore, the aim of this study is to investigate the nutritional status of inpatients with neurology disorders in China, evaluate the impact of different nutritional status on patients' health outcomes, and establish a high-quality, standardized nutrition and health cohort database for neurology disorders.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years;

The primary diagnosis was neurological disorders;

Written informed consent.

Disqualifiers

Life expectancy is < 3 months;

Researchers think other ineligible participant for the study.

Trial population

Participants with the primary diagnosis are neurological disoders

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

All-cause mortality

Mortality defined as all-cause mortality from inclusion to day 30

Time frame
30 days

Secondary outcomes

1

ICU admission

ICU admission defined as admission to the intensive care unit from the medical ward from inclusion to day 30

Time frame
30 days
2

Non-elective hospital readmission

Non-elective hospital readmission defined as non-scheduled hospital readmission after discharge from the index hospital stay to day 30

Time frame
30 days
3

Major complications

Major complications defined as the following complications occurring from inclusion (i.e., not present at the time of inclusion) to day 30 I. Adjudicated nosocomial infection or abscess requiring antibiotic treatment II. respiratory failure with need for invasive or non-invasive ventilation III. major cardiovascular events including stroke, intracranial bleeding, cardiac arrest, myocardial infarction with and without invasive procedure and pulmonary embolism IV. acute renal failure (defined by 2x increase of baseline creatinine or new requirement of dialysis do to volume overload or electrolyte disturbance) V. gastro-intestinal events (hemorrhage, intestinal perforation)

Time frame
30 days
4

Decline in functional status of 10% or more

decline in functional status of 10% or more from admission to day 30 measured by the Barthel's index.

Time frame
30 days

Other outcomes

1

Adverse events

Each of the adverse events

Time frame
30 days

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: